Edgar V. Lerma 🇵🇭 on X: @JochenReiser @Kidney_Int @goKDIGO See this study (ca. 2014) by @raja_1980 from @NDTsocial In patients with FSGS who had complete remission (CR), TAC dose was reduced to

Edgar V. Lerma 🇵🇭 on X: Pathogenesis based approach to

KDIGO - This week's KDIGO GN Speaker's Guide feature is Nephrotic

Edgar V. Lerma 🇵🇭 on X: @goKDIGO @Kidney_Int Membranous

Edgar Lerma on LinkedIn: #kdigoadpkd #nephpearls

Edgar V. Lerma 🇵🇭 on X: .@goKDIGO Practice Point 1.1.1

Edgar V. Lerma 🇵🇭 on X: Current CKD nomenclature used by

Edgar V. Lerma 🇵🇭 on X: .@goKDIGO Glomerular Diseases Guideline

Edgar V. Lerma 🇵🇭 on X: FSGS ca. 2021 from @Kidney_Int @goKDIGO

Edgar Lerma on LinkedIn: #kdigoadpkd #nephpearls